Dr. Kenneth A. Selzer Joins Company's Board of Directors
EXTON, Pa., Nov. 5 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (Amex: ILE) today announced the results of its 2007 Annual Meeting of Stockholders, held today in Exton, Pennsylvania.
Stockholders elected Dr. Kenneth A. Selzer to serve as a new Director. Dr. Selzer has been a partner with the venture capital firm of Finistere Ventures. Concurrently, since 2005, Dr. Selzer has been executive director of the Hallowell-West Medical Center, which specializes in the diagnosis and treatment of patients with Attention Deficient Disorders (ADD/ADHD) and associated learning disorders. From 2002 until 2005, Dr. Selzer was a general partner with Neuropractice Consulting Group, which provides specialized services for companies investing in drugs, biologics and medical devices. Dr. Selzer is currently on the Board of Directors of INC Research, a global clinical research organization (CRO) and a company which he founded in 1996. Dr. Selzer is a graduate of both the UCLA School of Medicine and the OPM executive management program at Harvard Business School and is a Diplomat of both the American Board of Neurology and the American Board of Pain Medicine.
"We are pleased to welcome Dr. Selzer to our Board of Directors," said Nicholas L. Teti, Chairman and CEO of Isolagen Inc. "Ken brings a wealth of clinical, medical and business knowledge to Isolagen and we look forward to benefiting from his broad experience."
Stockholders also re-elected Steven Morrell, Partner, Teknoinvest AS, and Marshall G. Webb, President of Polaris Group, as Directors.
The terms of these three Directors will run through the 2010 Annual Meeting of Stockholders.
Further, the Company's stockholders ratified the appointment of BDO Seidman, LLP as the Company's auditors for the year ending December 31, 2007.
About Isolagen, Inc.
|SOURCE Isolagen, Inc.|
Copyright©2007 PR Newswire.
All rights reserved